Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial.
about
Adjuvant therapy for high-risk localized kidney cancer- emerging evidence and future clinical trials.Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?The current status of adjuvant treatment for high-risk renal cell carcinoma.Targeting tumour microenvironment by tyrosine kinase inhibitor.High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis.Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis
P2860
Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Adjuvant Treatment for High-Ri ...... f the ASSURE Randomized Trial.
@en
type
label
Adjuvant Treatment for High-Ri ...... f the ASSURE Randomized Trial.
@en
prefLabel
Adjuvant Treatment for High-Ri ...... f the ASSURE Randomized Trial.
@en
P2093
P2860
P1433
P1476
Adjuvant Treatment for High-Ri ...... f the ASSURE Randomized Trial.
@en
P2093
Janice P Dutcher
Judith Manola
Michael B Atkins
Naomi B Haas
Robert G Uzzo
Robert S DiPaola
Toni K Choueiri
P2860
P356
10.1001/JAMAONCOL.2017.0076
P577
2017-03-09T00:00:00Z